Immunoglobulin G (IgG) antibodies are an essential part of the immune system, defending against infections and maintaining immune memory. These antibodies recognize and neutralize pathogens, providing long-term immunity after infection or vaccination. Beyond their biological role, IgG antibodies are widely used in biomedical research, diagnostics, and therapeutic applications.
Here are five key facts about IgG antibodies that highlight their importance in immunology and biopharmaceuticals.
Fact 1: IgG Is the Most Abundant Antibody in the Human Body
IgG antibodies are the most prevalent immunoglobulin in human serum, accounting for approximately 75-80% of total circulating antibodies. Their high concentration makes them the primary antibody involved in systemic immune responses. Unlike IgM, which is the first antibody produced during an infection, IgG is responsible for long-term immunity and secondary immune responses.
One of IgG’s defining characteristics is its long half-life, averaging 21 days in the bloodstream. This extended presence allows IgG to provide prolonged immunity after infection or vaccination. Additionally, IgG is the only antibody type capable of crossing the placenta, providing passive immunity to newborns by protecting them against infections during the first months of life.
There are four IgG subclasses (IgG1, IgG2, IgG3, and IgG4), each with their own properties:
IgG1 – The most abundant subclass, involved in responses to protein antigens and viral infections.
IgG2 – Plays a role in immune responses against bacterial polysaccharides, particularly encapsulated bacteria.
IgG3 – Has the strongest ability to activate the complement system and neutralize pathogens.
IgG4 – Associated with tolerance and regulation of immune responses, often involved in chronic conditions and allergies.
Because of these distinct functions, IgG subclass levels are often measured in diagnostic tests to assess immune deficiencies or specific disease states.
Fact 2: IgG Antibodies Are Highly Specific to a Wide Range of Antigens
The primary function of IgG is to recognize and neutralize pathogens, a task it performs with high specificity. Each IgG molecule is produced by B cells in response to a unique antigen, allowing the immune system to target a vast array of viruses, bacteria, fungi, and toxins. Upon first exposure to a pathogen, the immune system generates memory B cells, which enable a faster and stronger IgG response upon re-exposure to the same antigen.
Common infections that trigger strong IgG responses include:
Influenza – IgG antibodies generated after infection or vaccination protect against future flu strains.
Hepatitis B and C – Long-lasting IgG antibodies help prevent reinfection or reduce disease severity.
SARS-CoV-2 (COVID-19) – Neutralizing IgG antibodies play a key role in post-infection immunity and vaccine-induced protection.
Epstein-Barr Virus (EBV) – IgG antibodies can persist for a lifetime, serving as markers of past infection.
Varicella-Zoster Virus (VZV) – IgG provides immunity against chickenpox and shingles after vaccination or infection.
IgG’s ability to recognize and neutralize such a diverse range of antigens is why it is a key target in vaccine development and disease monitoring.
DOI: 10.1016/B978-0-323-95702-1.00066-X
Fact 3: IgG Blood Tests Are Diagnostic Tools
Measuring IgG levels in the blood is a widely used diagnostic method to assess immune function, detect infections, and monitor vaccine efficacy. Serology tests that measure IgG concentrations help determine whether an individual has developed immunity to a particular pathogen. These tests are commonly used for:
Post-vaccination immunity assessment – IgG levels indicate whether a vaccine has successfully induced an immune response.
Infection history evaluation – The presence of specific IgG antibodies can confirm past infections, even in asymptomatic individuals.
Autoimmune disease diagnosis – Abnormally high IgG levels are linked to conditions such as lupus, rheumatoid arthritis, and multiple sclerosis.
Primary and secondary immunodeficiency screening – Low IgG levels may indicate congenital immune disorders or acquired immune deficiencies.
In recent years, IgG antibody tests have been widely used for detecting past COVID-19 infections, helping public health officials track immunity levels in populations. Additionally, IgG tests are employed in allergy diagnostics, where elevated levels of IgG4 may indicate immune system tolerance to specific allergens.
A rapid SARS-CoV-2 IgM-IgG combined antibody test. DOI: 10.1101/2020.10.09.20209866
Fact 4: IgG Deficiency Increases the Risk of Infections
IgG deficiency can lead to an increased susceptibility to bacterial and viral infections, as the immune system struggles to neutralize pathogens effectively. There are different types of IgG deficiencies, ranging from selective IgG subclass deficiencies to common variable immunodeficiency (CVID), a more severe condition characterized by low levels of all immunoglobulin types.
People with IgG deficiency often experience recurrent infections, particularly in the respiratory and gastrointestinal tracts. Common symptoms include:
Frequent sinus and ear infections
Persistent bronchitis or pneumonia
Chronic diarrhea caused by gut infections
Difficulty recovering from common colds and flu
Diagnosing IgG deficiency typically involves quantitative immunoglobulin testing, which measures total IgG and its subclasses. Depending on the severity, treatment may include immunoglobulin replacement therapy (IVIG or SCIG) to restore antibody levels and reduce infection risk.
In some cases, individuals with mild IgG deficiency can manage symptoms through preventative antibiotics and lifestyle changes to strengthen overall immunity. Understanding and monitoring IgG levels is crucial for early intervention and effective management of immunodeficiency disorders.
Fact 5: IgG Antibodies Are Essential in Biopharmaceuticals
Beyond their role in the immune system, IgG antibodies are indispensable in the biopharmaceutical industry. Recombinant IgG monoclonal antibodies (mAbs) have transformed medicine, leading to the development of highly specific therapies for a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases.
Therapeutic IgG antibodies are commonly used in:
Cancer immunotherapy – Monoclonal IgG antibodies, such as trastuzumab (Herceptin) and pembrolizumab (Keytruda), target cancer cells and enhance immune system attack.
Autoimmune disease treatment – IgG-based biologics like adalimumab (Humira) and rituximab (Rituxan) are used for rheumatoid arthritis, multiple sclerosis, and lupus.
Infectious disease management – Neutralizing IgG antibodies have been developed for Ebola, COVID-19, and RSV (respiratory syncytial virus) treatment.
Diagnostic applications – IgG-based assays are widely used in ELISA, Western blot, and flow cytometry to detect disease markers.
Recombinant antibody technology continues to advance, with bispecific antibodies and antibody-drug conjugates (ADCs) representing the next generation of targeted therapies. Companies specializing in custom recombinant antibody production play a vital role in the development of new biologics, enabling precision medicine approaches to disease treatment.
At Biointron, we are dedicated to accelerating antibody discovery, optimization, and production. Our team of experts can provide customized solutions that meet your specific research needs, including HTP Recombinant Antibody Production. Contact us to learn more about our services and how we can help accelerate your research and drug development projects.
